Raymond James Financial and Benchmark issued rating upgrades and price targets for Axos Financial.
4 reports, 2 independent
Updated Oct 7
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Raymond James Financial and Benchmark issued rating upgrades and price targets for Axos Financial.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Axos Financial
bank holding company
Nothing else this week.
-
Raymond James Financial
American Investment Bank and Financial Services Firm
-
Benchmark
venture capital firm
Related events
- Analyst coverage for Septerna, including a new outperform rating from Raymond James Financial and coverage assumption by Truist Financial, reported via MarketBeat.
- Raymond James Financial restated a strong-buy rating and Truist Financial assumed coverage on Construction Partners shares.
- Raymond James Financial reaffirmed a strong-buy rating and Morgan Stanley set a $25.00 price objective for VIR Biotechnology.
- Financial firms Raymond James, CITIC Securities, and Amundi issued rating updates and target price changes for Apple Inc. stock.
- Raymond James Financial upgraded Aktis Oncology, Inc. to a strong-buy rating on June 17, 2026.